The company’s shares were up nearly 11 per cent at $8.32. The cash-strapped company also entered a stock deal with SK Bioscience worth about $85 million for part payment of a settlement amount owed to the South Korean company for manufacturing Novavax’s COVID-19 vaccines., The company’s shares were up nearly 11 per cent at $8.32. The cash-strapped company also entered a stock deal with SK Bioscience worth about $85 million for part payment of a settlement amount owed to the South Korean company for manufacturing Novavax’s COVID-19 vaccines., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way